🇺🇸 FDA
Patent

US 9598454

Mannose derivatives for treating bacterial infections

granted A61KA61K31/7028A61K31/7034

Quick answer

US patent 9598454 (Mannose derivatives for treating bacterial infections) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/7028, A61K31/7034, A61K31/7036, A61K31/7042